Expand ALPN Menu
ALPN MENU

ALPN Latest Press Releases

-- April 17, 2024 --

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN PRNewswire 7:50 PM

-- April 16, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRC, ALPN, NXPL Globe Newswire 8:11 AM

-- April 13, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, ALPN, ELYM, JBT Globe Newswire 9:29 AM

-- April 12, 2024 --

ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN Business Wire 5:17 PM

-- April 11, 2024 --

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm PRNewswire 4:27 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN PRNewswire 1:02 PM

-- April 10, 2024 --

Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex PRNewswire 9:50 PM
ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders Business Wire 8:08 PM
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy Business Wire 4:15 PM
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences Business Wire 4:01 PM

-- April 1, 2024 --

Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024 Business Wire 9:00 AM

-- March 21, 2024 --

Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024 Business Wire 7:45 AM

-- March 20, 2024 --

Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Business Wire 4:30 PM

-- March 18, 2024 --

Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results Business Wire 4:05 PM

-- March 7, 2024 --

Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results Business Wire 4:30 PM

-- February 26, 2024 --

Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences Business Wire 4:30 PM

-- February 1, 2024 --

Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences Business Wire 4:30 PM

-- December 21, 2023 --

Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie Business Wire 4:15 PM

-- December 18, 2023 --

Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference Business Wire 4:30 PM

-- November 20, 2023 --

Alpine Immune Sciences to Participate in the Evercore ISI HealthconX Conference Business Wire 4:30 PM